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Trends in Opioid Use in Pediatric Patients
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Daniel M. Tomaszewski, PharmD, PhD; Cody Arbuckle, PhD; Sun Yang, BSPharm, PhD; Erik Linstead, PhD
Abstract
IMPORTANCE The use of opioids to treat pain in pediatric patients has been viewed as necessary;
however, this practice has raised concerns regarding opioid abuse and the effects of opioid use. To
effectively adjust policy regarding opioids in the pediatric population, prescribing patterns must be
better understood.
OBJECTIVE To evaluate opioid prescribing patterns in US pediatric patients and factors associated
with opioid prescribing.
DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study used publicly available data
from the National Hospital Ambulatory Medical Care Survey from January 1, 2006, to December 31,
2015. Analysis included the use of bivariate and multivariate models to evaluate factors associated
with opioid prescribing. Practitioners from emergency departments throughout the United States
were surveyed, and data were collected using a representative sample of visits to hospital
emergency departments. The study analyzed all emergency department visits included in the
National Hospital Ambulatory Medical Care Survey for patients younger than 18 years. All statistical
analysis was completed in June of 2018 and updated upon receiving reviewer feedback in October
of 2018.
EXPOSURES Information regarding participants’ medications was collected at time of visit.
Participants who reported taking 1 or more opioids were identified.
MAINOUTCOMESANDMEASURES Evaluation of opioid prescribing patterns across demographic
factors and pain diagnoses.
RESULTS A total of 69 152 visits with patients younger than 18 years (32 727 female) were included,
which were extrapolated by the National Hospital Ambulatory Medical Care Survey to represent
293 528632 visits nationwide, with opioid use representing 21 276 831 (7.25%) of the extrapolated
visits. Factors including geographic region, race, age, and payment method were associated with
statistically significant differences in opioid prescribing. The Northeast reported an opioid
prescribing rate of 4.69% (95% CI, 3.69%-5.70%) vs 8.84% (95% CI, 6.82%-10.86%) in theWest
(P = .004). White individuals were prescribed an opioid at 8.11% (95% CI, 7.23%-8.99%) of visits vs
5.31% (95% CI, 4.31%-6.32%) for nonwhite individuals (P < .001). Those aged 13 to 17 years were
significantly more likely to receive opioid prescriptions (16.20%; 95% CI, 14.29%-18.12%) than those
aged 3 to 12 years (6.59%; 95% CI, 5.75%-7.43%) or 0 to 2 years (1.70%; 95% CI, 1.42%-1.98%).
Patients using Medicaid for payment were less likely to receive an opioid than those using private
insurance (5.47%; 95%CI, 4.79%-6.15% vs 9.73%; 95%CI, 8.56%-10.90%). There was no significant
difference in opioid prescription across sexes. Opioid prescribing rates decreased when comparing
2006 to 2010 with 2011 to 2015 (8.23% [95% CI, 6.75%-9.70%] vs 6.30% [95% CI, 5.44%-7.17%];
(continued)
Key Points
Question How has opioid use in
pediatric patients changed over the past
10 years, and what factors are
associated with differences in
opioid use?
Findings A cross-sectional study of
69 152 emergency department visits
found that opioid prescribing rates
decreased between 2006 to 2010
(8.23%) and 2011 to 2015 (6.30%).
Region, race, age, and payment method
were associated with differences in
opioid prescribing.
Meaning Opioid rates have decreased
in recent years but inconsistencies in
prescribing continue, suggesting the
need for further research.
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Abstract (continued)
P < .001); however, opioid prescribing rates remained unchanged in specific pain diagnoses,
including pelvic and back pain.
CONCLUSIONS ANDRELEVANCE This research demonstrated an overall reduction in opioid use
among pediatric patients from 2011 to 2015 compared with the previous 5 years; however, there
appear to be variations in factors associatedwith opioid prescribing. The association of location, race,
paymentmethod, and pain diagnoseswith rates of prescribing of opioids suggests areas of potential
quality improvement and further research.
JAMA Network Open. 2018;1(8):e186161. doi:10.1001/jamanetworkopen.2018.6161
Introduction
Acute pain is common among pediatric patients presenting to hospital emergency departments
(EDs).1 The cause of pediatric pain disorders includes, but is not limited to, headaches, abdominal
pain, back pain, musculoskeletal injury, postoperative pain, and cancer-related pain. In the treatment
ofmoderate and severe acute pediatric pain, it can be difficult to balance the risks of treatmentwhile
providing adequate pain control. Health care practitioners often must choose between the use of
opioids, traditional nonnarcotic agents (including nonsteroidal anti-inflammatory drugs and
acetaminophen), and nonpharmacological options.
The use of opioids to treat moderate to severe pain in pediatric patients for specific pain
disorders has generally been considered appropriate and necessary; however, recent concerns
regarding opioid abuse and increases in opioid-related hospitalizations and deaths among pediatric
patients have raised questions about the practice of prescribing opioids for management of pain in
children.2 Although not as extensive as in adults, the use of opioids in pediatric patients had seen a
significant increase prior to 2010, with the rate of opioid prescribing doubling from 1994 to 2007 in
pediatric patients.3 More specifically, ED prescribing of opioids in pediatric patients increased from
occurring in 11.2% of visits in 2001 to 14.5% in 2010.4 Additionally, studies5 suggest that when
opioids are prescribed to pediatric patients, approximately 60% of opioid prescriptions dispensed
includemore opioids than are needed to treat the acute pain disorder.
Recent studies6 have shown that as opioid prescribing has increased in pediatric patients, the
rate of opioid abuse and opioid-related death have also increased among these patients. Additionally,
in recent years, as opioid prescribing rates have actually declined among pediatric patients, opioid-
related hospitalizations have continued to increase.7 This continued trend reinforces the potential
risk associated with opioid use in pediatrics, with increased likelihood and accelerated progression
from use to abuse in pediatric populations.8 Research has shown that young people who report
receiving a legitimate prescription for a narcotic pain medication by 12th grade are significantly more
likely to abuse prescription pain medications in the future.9,10 This risk for misuse has also been
shown among pediatric patients who report nonmedical use of opioids prior to adulthood.11 The risks
associated with use of opioids at an early age suggest the need for further review of opioid
prescribing in pediatric patients.
This study aims to evaluate trends of pediatric opioid prescribing in EDs in US hospitals and
patient-related factors associated with opioid prescribing.
Methods
This study analyzes data collected from the 2006 to 2015 National Hospital AmbulatoryMedical Care
Survey (NHAMCS) focusing on patients younger than 18 years. This survey is conducted using a
representative sample of visits to EDs, collecting data frommedical records on patients’ symptoms,
diagnoses, comorbidities, demographic characteristics, and medications ordered or provided. The
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survey uses a complex 4-stage study design. A description of the sampling design is available
elsewhere.12,13 Prior to completion of this study, the Chapman University institutional review board
reviewed and granted this study exempt status, as the analysis of deidentified, publicly available data
does not constitute human subjects research as defined in federal regulations and as such does not
require review. Hence, informed consent was not necessary. The study followed the Strengthening
the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
The NHAMCS data were weighted by the Centers for Disease Control and Prevention (CDC)
using themost recent census data to most accurately represent national hospital visit and patient
population characteristics. All analyses were conducted on weighted data, as recommended by the
CDC’s National Center for Health Statistics, to be representative of national hospital visit
characteristics. The use of opioids was determined using the CDC’s New Ambulatory Care Drug
Database system, with drugs being classified as opioid or other.14 Medications included all drugs
reported as either ordered as a prescription or provided during the visit.
A visit was considered pain related if a pain diagnosis was reported in the reasons for the visit
through the evaluation of reported International Classification of Diseases, Ninth Revision, Clinical
Modification codes. Pain diagnosis codes were established based on the clinical classification
software categories available from the Agency for Healthcare Research and Quality Healthcare Cost
and Utilization project. Included pain categories were abdominal pain, arthritis or joint pain, back
pain, cancer-related pain, chest pain, cholelithiasis, fractures, headache, injury excluding fracture,
neck pain, nephrolithiasis, pelvic pain, sickle cell anemia, dental or jaw pain, fibromyalgia, and
peripheral neuropathy. Pain categories that did not meet theminimum of 30 visits in the unweighted
sample were recategorized into a category labeled other pain.
Metropolitan setting of the visit was determined usingMetropolitan andMicropolitan Statistical
Areamethodology, the definition used by federal agencies for research purposes. Length of visit was
recoded into dichotomous categories of prolonged (lasting >240minutes) or not prolonged (lasting
240minutes).
Statistical Analysis
All participants’ records were stored in a relational database using the open-source database
softwareMySQL version 5.7.11 (Oracle). All statistical analyses were preformed using the open-source
statistical computing software R version 3.2.3 (R Foundation) and finalized October 12, 2018. The
function svydesign from the R package survey was used to account for stratified, clustered, and
weighted variables in the NHAMCS data. AWald test of association was used to determine
significance for all analyses.
Descriptive statistics were used to compare the characteristics of ED visits associated with
opioids with those in which patients were not currently prescribed an opioid. Wald tests of
association were used to determine significance for bivariate analysis, and logistic regressionmodels
were conducted using weighted patient data with opioid use as the dependent variable and age,
race, sex, pain diagnosis, paymentmethod, region, and length of ED visit as dependent variables. The
model was simultaneously adjusted for all dependent variables.
All confidence intervals correspond to 95% CIs, as computed from the standard error.
Comparison and associations were considered significant if 2-sided P < .05. All analysis conducted
used cohorts of more than 30 visits and had a relative standard error of less than 30% per CDC
guidelines. The CDC provided detailed documentation of the NHAMCS instrument, methodology,
and data files that were used as the basis for this analysis and are available elsewhere.12
Results
A total of 69 152 hospital ED visits by patients younger than 18 years at the time of the visit (32 727
female) from January 1, 2006, through December 31, 2015, were included. These visits were
extrapolated by the National Hospital Ambulatory Medical Care Survey to represent 293 528632
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hospital ED visits throughout the United States, with 7.25% (95% CI, 6.43%-8.06%) of those visits
(21 276 831) associated with either being currently prescribed an opioid or attaining one from the
visit. Among pediatric patients, those aged 13 to 17 years were significantly more likely to have visits
associated with opioid administration and/or prescription, with 16.20% (95% CI, 14.29%-18.12%) of
individuals aged 13 to 17 years having an opioid prescribed compared with 6.59% (95% CI,
5.75%-7.43%) for those aged 3 to 12 years and 1.70% (95% CI, 1.42%-1.98%) for those aged 0 to 2
years (P < .001).
Significant differences in opioid prescription rates were observed across varying demographic
factors. White participants reported an average opioid prescription rate of 8.11% (95% CI,
7.23%-8.99%) vs 5.31% (95% CI, 4.31%-6.32%) for nonwhite participants (P < .001). The likelihood
of a visit being related to an opioid prescription was also statistically significant when comparing
regions of the country, with visits occurring in the Northeast being associated with the lowest
prescribing rate, having an average prescription rate of 4.69% (95% CI, 3.69%-5.70%) compared
with 8.84% (95% CI, 6.82%-10.86%) for theWest, the highest-prescribing region (P = .004).
Patients using Medicaid for payment were less likely to receive an opioid than those using private
insurance (5.47%; 95% CI, 4.79%-6.15% vs 9.73%; 95% CI, 8.56%-10.90%). The population density
of the areawhere the individual received care did not appear to be associatedwith overall prescribing
rates of opioids, with similar opioid prescribing rates betweenmetropolitan and nonmetropolitan
areas. Further details on cohort size and weighted and unweighted visit counts, as well as opioid
prescription rates based on specific demographics throughout the cohorts, are available in Table 1.
The use of opioids in pediatric patients varies significantly based on the reported diagnosis
related to the visit (Table 2). Visits associated with a bone fracture had the highest rate of opioid
prescribing, with 41.30% (95% CI, 36.20%-46.40%) of all visits having an opioid prescribed. Pelvic
pain, back pain, and other pain had the next-highest likelihood of having an opioid prescribed, with
21.21% (95% CI, 15.77%-26.65%), 20.99% (95% CI, 14.83%-27.15%), and 21.28% (95% CI,
16.11%-26.45%) of visits having an opioid prescribed, respectively. Injuries other than fractures were
the least likely pain diagnosis to result in an opioid prescribed, with 9.75% (95% CI, 8.38%-11.13%)
of visits having an opioid prescribed. Headaches, arthritis or joint pain, and abdominal pain had
similar opioid prescribing rates per visit (16.57% [95%CI, 12.58%-20.57%], 15.27% [95%CI, 10.66%-
19.88%], and 15.01% [95% CI, 12.29%-17.73%], respectively).
Logistic regression was used to analyze the association of demographic factors and pain
diagnosis with the rate of visits during which an opioid was prescribed (Table 3). Age, race, sex, pain
diagnosis, region of care, length of visit, and payment method were used as independent variables
with opioid prescription as the dependent variable. Comparing the adjusted odds ratios (aORs) of the
age groups showed that the aOR of a visit being associated with an opioid prescriptionmore than
doubled as age increased, using 13 to 17 years as the reference cohort. The age cohort of 0 to 2 years
had an aOR of 0.14 (95% CI, 0.12-0.16) and the age group of 3 to 12 years had an aOR of 0.41 (95%
CI, 0.38-0.45). All pediatric age groups had a lower rate of opioid prescribing than all adult age
groups, with the 13 to 17 years group being roughly half as likely as the 18 to 24 years group to be
prescribed an opioid; however, 16.20% (95% CI, 14.29%-18.12%) of those aged 13 to 17 years with an
ED visit were still prescribed an opioid.
Comparing opioid prescribing based on pain diagnosis revealed variable opioid prescribing rates
dependent on the specific diagnosis. All non–pain diagnosis–related visits were used as the referent
group, which had an overall opioid prescribing rate of 3.62% (95% CI, 3.16%-4.08%). Patients
diagnosed with pain associated with a fracture had the greatest likelihood of being prescribed an
opioid, with an aOR of 14.27 (95% CI, 12.60-16.16) when compared with the referent group. Pelvic
pain and arthritis or joint–related pain were the next 2 pain diagnoses most likely to result in opioid
prescribing, with aORs of 5.12 (95% CI, 3.80-6.92) and 4.84 (95% CI, 3.61-6.50), respectively. Visits
associated with headaches and abdominal pain diagnoses had similar likelihood of opioid use, with
aORs of 2.89 (95% CI, 2.21-3.77) and 2.69 (95% CI, 2.25-3.21), respectively.
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Logistic regression analysis of payment method and opioid use demonstrated similar opioid
prescribing rates among those who reported using private insurance, Medicare, and self-pay. Those
using Medicaid as their primary payment method had a significantly lower likelihood of being
prescribed an opioid, with an aOR of 0.74 (95% CI, 0.67-0.81) compared with those using private
insurance. Comparing opioid prescribing in patients based on race revealed that white patients were
more likely to be prescribed an opioid, with an aOR of 1.34 (95% CI, 1.19-1.50) compared with
nonwhite patients. There was no difference in opioid prescribing between sexes, with female
patients having an aOR of 1.03 (95% CI, 0.93-1.13) compared with male patients.
To analyze changes over time in opioid prescribing rates based on specific pain diagnoses, the
original data set was separated into two 5-year cohorts, 2006 to 2010 and 2011 to 2015. Overall
opioid prescription rates were significantly lower in the 2011 to 2015 cohort, decreasing from 8.23%
(95%CI, 6.75%-9.70%) to 6.30% (95%CI, 5.44%-7.17%) (P < .001). Specifically, opioid prescribing
rates for headaches, which had an overall prescribing rate of 16.6%, decreased from 21.93% (95% CI,
14.96%-28.90%) to 12.51% (95% CI, 7.54%-17.47%) (P = .008). The opioid prescribing rates for
Table 1. Emergency Department Visits for US Pediatric Patients, 2006-2015a
Variable
Total Visits Visits With Opioid Prescription
P ValuebUnweighted, No. Weighted, No. Unweighted, No. Weighted, No. Weighted, % (95% CI)
All visits 69 152 293 528 632 4910 21 276 831 7.25 (6.43-8.06)
Age, y
0-2 22 515 95 677 472 403 1 626 298 1.70 (1.42-1.98) [Reference]
3-12 30 213 129 048 017 1919 8 501 284 6.59 (5.75-7.43) <.001
13-17 16 424 68 803 143 2588 11 149 249 16.20 (14.29-18.12) <.001
Race
Nonwhite 22 436 90 203 294 1138 4 793 140 5.31 (4.31-6.32)
<.001
White 46 716 203 325 338 3772 16 483 691 8.11 (7.23-8.99)
Sex
Female 32 727 13 943 0654 2320 10 091 754 7.24 (6.32-8.16)
.95
Male 36 425 154 097 978 2590 11 185 077 7.26 (6.42-8.10)
Payment method
Medicaid 35 602 149 785 565 1961 8 189 855 5.47 (4.79-6.15) [Reference]
Private insurance 22 265 92 174 669 2104 8 972 087 9.73 (8.56-10.90) <.001
Self-pay 4769 20 897 238 392 1 810 064 8.66 (7.03-10.29) <.001
Other payment method 6516 30 671 160 453 2 304 825 7.51 (5.77-9.26) <.001
Region
Midwest 16 092 64 297 373 1104 4 411 876 6.86 (5.42-8.30) [Reference]
Northeast 14 943 48 114 360 620 2 258 130 4.69 (3.69-5.70) <.001
South 25 357 122 818 883 2078 9 453 757 7.70 (6.23-9.16) .12
West 12 760 58 298 016 1108 5 153 068 8.84 (6.82-10.86) .004
Metropolitan setting
Metropolitan area 54 750 223 751 850 3888 16 127 742 7.21 (6.13-8.28)
.93
Nonmetropolitan area 8224 42 120 692 614 3 156 909 7.49 (4.22-10.77)
Length of visit
Not prolonged (≤240 min) 55 783 239 294 579 3728 18 814 630 6.79 (5.99-7.58) [Reference]
Prolonged (>240 min) 10 229 38 880 272 1043 1 644 250 10.86 (9.48-12.23) <.001
Unknown or missing data 3140 15 353 781 139 817 951 5.33 (3.07-7.58) .01
Episode of care
Follow-up visit to this
emergency department
2540 9 869 291 211 807 085 8.18 (6.48-9.88) [Reference]
Initial visit to this
emergency department
52 155 233 274 583 3715 16 734 073 7.17 (6.36-7.99) .17
Unknown or missing data 14 457 50 384 758 984 3 735 673 7.41 (6.04-8.79) .37
a All analyses account for the complex sampling design of the National Hospital
Ambulatory Medical Care Survey.
b P values calculated withWald test.
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non–fracture-related injuries, abdominal pain, and non–pain-related visits also decreased over this
time (Table 4). Additionally, opioid use in non–pain-related visits decreased from occurring in 4.07%
of visits to 3.18% of visits. Other diagnoses, including pelvic pain, fractures, back pain, and arthritis
or joint pain, did not have a statistically significant reduction in opioid prescribing over the same
period. Further details are available in Table 4.
Discussion
The potentially addictive nature of opioids, coupled with their widespread use, has led tomajor
discussions throughout the US health care system regarding the safety and effectiveness of using
opioids overall. Opioid use in pediatrics has beenmet with additional clinical and ethical questions,
with the latest CDC recommendation for opioid use in chronic pain suggesting that opioid use in
pediatrics, particularly adolescents, be avoided whenever possible.15 Althoughmuch of the focus of
better management of opioid use has focused on the adult population, several researchers have
expressed concerns regarding the overprescription of opioids and excessive prescriptions for opioids
in pediatric patients. The prescribing of opioids to pediatric patients is of particular concern because
of this group’s increased risk of addiction and the potential long-term effects related to opioid abuse
in pediatric patients.8,16
The use of opioids in pediatric patients in certain clinical circumstances is appropriate and
necessary. The intent of this review is to evaluate the trends of use in a number of clinical diagnoses
and evaluate patterns of use and inconsistencies, if any, in the use of opioids. For instance, the use of
opioids to treat pain associated with an injury resulting in a bone fracture is likely appropriate, but
an evaluation of patient-specific factors associated with prescribing trends in patients with fractures
helps to assess consistency in use.
However, despite the importance of understanding the prescribing trends related to pediatric
opioid use, very little research has been done in this area. The analysis presented here reveals that a
large portion of the pediatric population continues to be prescribed opioids when being treated in
EDs, with significant variations related to race, age, diagnosis, payment method, and region of the
country where the patient visit occurred.
As anticipated, age had a significant association with the use of opioids, both in pediatric
patients and adults. Those aged 13 to 17 years were significantly more likely to have visits associated
with opioid use (16.20%of visits) comparedwith those aged 3 to 12 years (6.59%of visits) and0 to
2 years (1.70% of visits). Although the overall rate of opioid prescribing for pediatric patients was
lower than for adults, the fact that more than 16% of all visits for those aged 13 to 17 years have an
opioid associated with them suggests that overall opioid use is also relatively high in pediatric
patients. The rate of opioid prescribing related to headaches in this study was 16.6%, which was
significantly lower than the previously reported rate of 46%.17 This difference in reporting is likely
Table 2. Opioid Prescription Rates by Pain Diagnosisa
Pain Category
Total Visits Visits With Opioid Prescription
Unweighted,
No.
Weighted,
No.
Unweighted,
No.
Weighted,
No.
Weighted,
% (95% CI)
Not pain related 48 269 205 295 925 1718 7 425 946 3.62 (3.16-4.08)
Abdominal pain 2578 11 306 345 357 1 697 014 15.01 (12.29-17.73)
Arthritis or joint pain 635 2 632 174 97 401 903 15.27 (10.66-19.88)
Back pain 385 1 710 840 80 359 075 20.99 (14.83-27.15)
Fractures 2692 10 674 632 1043 4 408 498 41.30 (36.20-46.40)
Headache 919 4 186 025 158 693 811 16.57 (12.58-20.57)
Injury excluding
fracture
12 305 51 975 509 1165 5 069 429 9.75 (8.38-11.13)
Other pain category 703 2 820 299 147 600 279 21.28 (16.11-26.45)
Pelvic pain 666 2 926 883 145 620 876 21.21 (15.77-26.65)
a All analyses account for the complex sampling design
of the National Hospital Ambulatory Medical
Care Survey.
JAMANetworkOpen | Pediatrics Opioid Use in Pediatric Patients in US Emergency Departments From 2006 to 2015
JAMA Network Open. 2018;1(8):e186161. doi:10.1001/jamanetworkopen.2018.6161 (Reprinted) December 21, 2018 6/11
Downloaded From:  by a SCELC - Chapman University User  on 01/02/2019
due to the nature of the data provided, with the data restricted to a single visit, vs previous reports
reviewing all prescription drug use over a full year. Additionally, previous research focused on opioid
use in the treatment of headaches, specifically in patients aged 13 to 17 years, and this study includes
analysis of use across all patients aged 17 years and younger.
Time-lapse analysis does show a reduction in overall opioid use comparing 2006 to 2010with
2011 to 2015. This reduction suggests that the scrutiny of the safety of opioid use overall and
particularly in pediatric patients has resulted in prescribers reevaluating their use of opioids overall.
This reduction in use is primarily driven by reductions in opioid use in specific pain diagnoses,
including headache, abdominal pain, and non–fracture-related injuries. The overall reductions were
also partially the result of reduced opioid use in non–pain-related visits, which decreased from
occurring in 4.07% of visits to 3.18%. The lack of change over time in the use of opioids for other pain
diagnoses, particularly back and pelvic pain, suggests that alternative treatment options need to be
further evaluated or encouraged among health care professionals. The use of opioids in back pain is
Table 3. Logistic Regression Analysis of Opioid Prescription Ratesa,b
Characteristic Adjusted Odds Ratio (95% CI)
Age, y
0-2 0.14 (0.12-0.16)
3-12 0.41 (0.38-0.45)
13-17 1 [Reference]
Race
Nonwhite 1 [Reference]
White 1.34 (1.19-1.50)
Sex
Male 1 [Reference]
Female 1.03 (0.93-1.13)
Pain diagnosis
Not pain related 1 [Reference]
Abdominal pain 2.69 (2.25-3.21)
Arthritis or joint pain 4.84 (3.61-6.50)
Back pain 4.27 (2.93-6.23)
Fractures 14.27 (12.60-16.16)
Headache 2.89 (2.21-3.77)
Injury excluding fracture 2.06 (1.83-2.32)
Other pain category 4.15 (3.12-5.52)
Pelvic pain 5.12 (3.80-6.92)
Payment method
Private 1 [Reference]
Medicaid 0.74 (0.67-0.81)
Other or unknown 0.90 (0.77-1.07)
Self-pay 0.96 (0.82-1.13)
Region
Midwest 1 [Reference]
Northeast 0.59 (0.50-0.69)
South 1.30 (1.13-1.50)
West 1.36 (1.14-1.62)
Prolonged emergency department visit
Unknown or missing data 1 [Reference]
Not prolonged (≤240 min) 1.23 (0.92-1.65)
Prolonged (>240 min) 2.08 (1.54-2.82)
a All analyses account for the complex sampling design of the National Hospital
Ambulatory Medical Care Survey.
b Themodel was simultaneously adjusted for the covariates listed.
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of significant concern because growing research suggests that chronic use of opioids to treat back
pain is not effective for both pain and function and is associated with significant safety concerns.
Our findings indicate that patient visits in the western region of the country (Alaska, Arizona,
California, Colorado, Hawaii, Idaho, Montana, Nevada, NewMexico, Oregon, Utah, Washington, and
Wyoming) are significantly more likely to be prescribed an opioid, while patients visits in the
Northeast (Connecticut, Maine, Massachusetts, NewHampshire, New Jersey, New York,
Pennsylvania, Rhode Island, and Vermont) are associated with the lowest likelihood of an opioid
being prescribed despite a lack of significant difference in pain-related diagnosis in these region.
Factors affecting the regional variability in opioid prescribing in pediatric patients need to be further
evaluated to better understandwhatmay be driving the overall prescribing patterns in each region,
particularly those with higher opioid prescribing rates.
Race additionally had a significant association with overall prescription trends, with white
patients having a significantly increased likelihood of being prescribed an opioid compared with
nonwhite patients. These findings are similar to previous research that has indicated significant racial
differences in prescription patterns of opioids in adult patients.18-20When holding constant for pain
diagnosis, white patients were significantly more likely to receive an opioid. For instance, white
patients reporting abdominal pain were almost twice as likely to receive an opioid than their
nonwhite counterparts. While there are numerous potential explanations for this difference, further
subset analysis is needed to better evaluate the use of opioids based on race to determine the
association of pain scale reports, age at time of visit, other patient-specific factors, and prescriber-
specific factors with opioid prescribing across racial and ethnic groups.
Similar to previous research, individuals whose primary payment method reported was state
Medicaid had a lower likelihood of being prescribed an opioid.21 This raises questions regarding the
biases that may exist in prescribers when treating patients covered by state Medicaid programs,
which appears to be true in pediatric patients as well as adults. This study’s analysis found that, unlike
previous studies in adults, prescribing rates were similar between sexes.
The relationship between opioid use rates in pediatric patients and pain diagnoses suggests that
different pain-related diagnoses are viewed by prescribers as more appropriate than others for
opioid use. As expected, pain related to fracture injuries had the highest rate of opioid prescribing,
which remained consistent when comparing 2006 to 2010with 2011 to 2015. The relatively high use
of opioids in pelvic pain and back pain, which also lack a statistically significant reduction over time,
suggests additional evaluation is necessary regarding prescribers’ attitudes toward treatment
options in these specific pain-related diagnoses. Although the percentage of visits for headache,
abdominal pain, non–fracture-related injuries, and non–pain-related diagnoses associated with
opioid use has decreased, the continued use of opioids suggests additional opportunity for further
evaluation and prescriber outreach to ensure appropriate and consistent prescribing of opioids. Each
of these pain diagnoses have limited need for the use of opioids, and the reduction of use over time
is a positive trend; however, more significant reductions of opioid use in these clinical circumstances
would be appropriate.
Limitations
Limitations of this study include its retrospective nature and the general limitations of using a cross-
sectional data set. Owing to this limitation, we can only report the findings of the analysis and are
not able to draw conclusions about the causative nature of factors associated with opioid prescribing
patterns. Additionally, this study is not able to determine which factors may have been associated
with a reduction in the use of opioids for specific pain diagnoses. Many factors may need to be
further explored to understand their role in opioid prescribing patterns. In addition, a number of
comorbidities and preexisting diseases may affect the choice of drug for pain management. For
example, opioid therapy is generally the first-line approach formoderate to severe pain control, alone
or in combination with other medications, in patients with active cancer, particularly when a patient
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is neutropenic. The presented study is not able to evaluate patients’ comorbidities or determine their
potential effects on opioid prescribing.
Conclusions
The findings of this study suggest the overall use of opioids in pediatric patients in EDs has declined
since 2010; however, further research is warranted given the remarkable variability in opioid
prescribing rates based on patient-specific demographic characteristics and pain-related diagnoses.
Although the use of opioids is indicated for specific pain-related visits, it is important to keep
prescribing consistent across all health care professionals regardless of patient demographic
characteristics. The lack of consistency in prescribing opioids observed in this study also indicates the
need to develop amore standardized opioid use guideline in pediatrics, which can help guide
prescribers to make informed decisions when considering opioids for the treatment of patients
younger than 18 years.
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